Digital program to help people with COPD manage their symptoms
Official title: Digital Tool for Improved Self-management of COPD
Run by Karolinska Institutet · NCT07573098 · Data updated 2026-11-12
This project will test a smartphone app combined with home spirometry to help adults with COPD who had at least one exacerbation in the past year manage their condition over six months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 1 site (Solna, Stockholm County) |
| Status | Recruiting |
| Started | December 5, 2025 |
| Main results expected | May 5, 2027 |
| Study ends | May 5, 2027 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT07573098 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40 or older with a documented COPD diagnosis using at least two inhaled medications and with at least one exacerbation in the past year who have an Android (v8+) or iOS (v16+) smartphone, access to BankID (or similar), and can perform home spirometry are the intended participants.
✕Probably not a fit
Patients with very severe COPD or other conditions that make home spirometry unsafe, those without compatible smartphones or electronic ID, pregnant or breastfeeding women, and people unable to give informed consent are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This open pilot feasibility study will enroll 50 adults with COPD and at least one exacerbation in the previous year. Participants will be onboarded to a digital platform (smartphone app plus home spirometry) and asked to follow personalized self-management guidance while researchers monitor feasibility, usability, and safety over six months. Secondary outcomes include the number and adequacy of healthcare contacts recorded during follow-up. Participants without compatible smartphones or electronic identification will be excluded and safety considerations will exclude those for whom home spirometry is unsafe.
Why it matters
Potential benefit: If successful, the digital tool could help people detect worsening symptoms earlier, strengthen self-management skills, and reduce respiratory-related healthcare visits or hospital admissions.
How similar studies have gone: Systematic reviews, including a 2022 Cochrane review, indicate that self-management interventions for COPD can improve quality of life and reduce respiratory-related admissions, though evidence specifically for digital tools is mixed and still emerging.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects from the age of 40 years with documented diagnosis of COPD, using at least two inhaled medications (one combination inhaler or several inhalers), and with at least one exacerbation within the last year will be invited to voluntarily participate. Exclusion Criteria: * Exclusion criteria is severe disease from either COPD or any severe concomitant conditions that would make home spirometry unsafe for the patient. Patients with no access to use BankID or similar electronic personal identification service and not using smartphones will be excluded. Also, individuals who are pregnant or breastfeeding women, and individuals who are unable to provide informed consent due to cognitive impairment or other reasons indicating lack of decision-making capacity will be excluded.
Where it's running
-
KPE Lung and Allergy, QB:84, Karolinska University Hospital.
Solna, Stockholm County, Sweden Recruiting
Study contacts
- Study coordinator: Henrik Ljungberg
- Email: henrik.ljungberg@ki.se
- Phone: +46706628642
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
-
Biomarker clues for COPD, IPF, and lung cancer
This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.
-
HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults
This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.